SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,920,696 | -30.4% | 1,129,823 | -6.8% | 0.00% | -50.0% |
| Q2 2023 | $5,634,815 | +4.0% | 1,211,788 | +3.3% | 0.00% | 0.0% |
| Q1 2023 | $5,419,886 | +100417.2% | 1,173,199 | +75.7% | 0.00% | 0.0% |
| Q4 2022 | $5,392 | -99.8% | 667,543 | +46.2% | 0.00% | +100.0% |
| Q3 2022 | $2,534,000 | +33.7% | 456,583 | +25.6% | 0.00% | 0.0% |
| Q2 2022 | $1,895,000 | -48.4% | 363,645 | -18.6% | 0.00% | 0.0% |
| Q1 2022 | $3,674,000 | -31.6% | 446,955 | +23.9% | 0.00% | -50.0% |
| Q4 2021 | $5,369,000 | +13.2% | 360,765 | +43.7% | 0.00% | 0.0% |
| Q3 2021 | $4,742,000 | -24.6% | 251,081 | -25.8% | 0.00% | 0.0% |
| Q2 2021 | $6,287,000 | -23.6% | 338,187 | -6.6% | 0.00% | -33.3% |
| Q1 2021 | $8,229,000 | +284.5% | 362,177 | +267.5% | 0.00% | +200.0% |
| Q4 2020 | $2,140,000 | – | 98,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |